HSAN Type IV
|
0.400 |
Biomarker
|
disease |
BEFREE |
This review focuses on the clinical and neurobiological aspects of CIPA and explains that NGF-dependent neurons in the peripheral nervous system play pivotal roles in interoception and homeostasis of our body, as well as in the stress response.
|
29407522 |
2018 |
HSAN Type IV
|
0.400 |
Biomarker
|
disease |
BEFREE |
Our findings imply that the genetic variations of the nerve growth factor-tropomyosin-related kinase A pathway play an important role in congenital insensitivity to pain with anhidrosis.
|
25316729 |
2015 |
HSAN Type IV
|
0.400 |
Biomarker
|
disease |
BEFREE |
In CIPA, the lack of pain and the presence of anhidrosis (inability to sweat) are due to the absence of both NGF-dependent primary afferents and sympathetic postganglionic neurons, respectively.
|
24494678 |
2014 |
HSAN Type IV
|
0.400 |
Biomarker
|
disease |
BEFREE |
Unravelling the mechanisms that underlie the differences between HSAN IV and V could assist in better understanding NGF biology.
|
24494679 |
2014 |
HSAN Type IV
|
0.400 |
Biomarker
|
disease |
BEFREE |
We will review neuropathies and clinical presentations that result from the disruption of NGF signalling in HSAN type IV and HSAN type V and review current advances in developing anti-NGF therapy for the clinical management of pain.
|
23157347 |
2013 |
HSAN Type IV
|
0.400 |
Biomarker
|
disease |
BEFREE |
Using the pathophysiology of CIPA as a foundation, this review investigates the ways in which NGF-dependent neurons contribute to interoception, homeostasis and emotional responses and, together with the brain, immune and endocrine systems, play crucial roles in pain, itch and inflammation.
|
22882139 |
2012 |
HSAN Type IV
|
0.400 |
Biomarker
|
disease |
BEFREE |
Congenital insensitivity to pain with anhidrosis (hereditary sensory and autonomic neuropathy type IV) is a rare autosomal recessive disorder caused by a defect in neurotrophic tyrosine kinase receptor and nerve growth factor, as reported in previous studies.
|
20647579 |
2010 |
HSAN Type IV
|
0.400 |
Biomarker
|
disease |
BEFREE |
Since patients with congenital insensitivity to pain with anhidrosis lack NGF-dependent unmyelinated (C-) and thinly myelinated (Aδ-) fibers, and their dermal sweat glands are without innervation, they exhibit no pain, itch, signs of neurogenic inflammation or sympathetic skin responses.
|
20977328 |
2010 |
HSAN Type IV
|
0.400 |
Biomarker
|
disease |
BEFREE |
Patients with CIPA provide us a rare opportunity to explore the developmental and physiological function of the NGF-dependent neurons in behavior, cognitive, and mental activities that are not available in animal studies.
|
19201660 |
2009 |
HSAN Type IV
|
0.400 |
GeneticVariation
|
disease |
BEFREE |
Congenital insensitivity to pain with anhidrosis (CIPA) is an autosomal recessive disorder caused by mutations in the neurotrophic tyrosine receptor kinase 1 (NTRK1) gene, which encodes the receptor for nerve growth factor.
|
19089473 |
2009 |
HSAN Type IV
|
0.400 |
Biomarker
|
disease |
BEFREE |
We hypothesized that HSAN IV represents a natural model for impaired NGF effect on the neuroendocrine system in humans.
|
15695606 |
2005 |
HSAN Type IV
|
0.400 |
GeneticVariation
|
disease |
BEFREE |
Congenital insensitivity to pain with anhidrosis (CIPA) is an autosomal recessive disorder caused by mutations in the neurotrophic tyrosine receptor kinase 1 (NTRK1) gene which encodes the receptor for nerve growth factor (NGF).
|
16138253 |
2005 |
HSAN Type IV
|
0.400 |
GeneticVariation
|
disease |
BEFREE |
The TrkA(mt/mt) EB-LCL derived from the CIPA patient and the TrkA(wt/mt) EB-LCL derived from the carrier with the heterozygous TrkA mutation did not show any responses to NGF on anti-apoptotic activity.
|
15114061 |
2004 |
HSAN Type IV
|
0.400 |
Biomarker
|
disease |
BEFREE |
We report a girl with clinical and neurophysiological findings consistent with a diagnosis of HSAN-V. We sequenced her TRKA gene, encoding a receptor tyrosine kinase for nerve growth factor and responsible for HSAN-IV, but we could not detect any mutation.
|
12210794 |
2002 |
HSAN Type IV
|
0.400 |
Biomarker
|
disease |
BEFREE |
In view of the fact that defects in TRKA cause CIPA, the molecular pathology of CIPA provides unique opportunities to explore critical roles of the NGF-TRKA receptor system.
|
12102460 |
2002 |
HSAN Type IV
|
0.400 |
GeneticVariation
|
disease |
BEFREE |
Congenital insensitivity to pain with anhidrosis (CIPA): effect of TRKA (NTRK1) missense mutations on autophosphorylation of the receptor tyrosine kinase for nerve growth factor.
|
11159935 |
2001 |
HSAN Type IV
|
0.400 |
GeneticVariation
|
disease |
BEFREE |
TRKA encodes the receptor tyrosine kinase (RTK) for nerve growth factor (NGF) and is the gene responsible for CIPA.
|
11748840 |
2001 |
HSAN Type IV
|
0.400 |
Biomarker
|
disease |
BEFREE |
Mutation and polymorphism analysis of the TRKA (NTRK1) gene encoding a high-affinity receptor for nerve growth factor in congenital insensitivity to pain with anhidrosis (CIPA) families.
|
10982191 |
2000 |
HSAN Type IV
|
0.400 |
Biomarker
|
disease |
BEFREE |
The human TRKA gene on chromosome 1q21-q22 encodes a receptor tyrosine kinase for nerve growth factor and is responsible for an autosomal recessive genetic disorder: congenital insensitivity to pain with anhidrosis (CIPA).
|
11071380 |
2000 |
HSAN Type IV
|
0.400 |
Biomarker
|
disease |
BEFREE |
Point mutations affecting the NTRK1/TRKA gene, encoding one of the receptors for the nerve growth factor (NGF), have been detected in congenital insensitivity to pain with anhidrosis (CIPA), a human hereditary sensory neuropathy characterized by absence of reaction to noxious stimuli and anhidrosis.
|
10567924 |
2000 |
HSAN Type IV
|
0.400 |
GeneticVariation
|
disease |
BEFREE |
Using the linkage analysis approach, we linked the disease in 9 of 10 unrelated Israeli-Bedouin families with CIPA to the TrkA gene, which encodes the receptor for nerve growth factor.
|
10861667 |
2000 |
HSAN Type IV
|
0.400 |
GeneticVariation
|
disease |
BEFREE |
Congenital insensitivity to pain with anhidrosis: novel mutations in the TRKA (NTRK1) gene encoding a high-affinity receptor for nerve growth factor.
|
10330344 |
1999 |
HSAN Type IV
|
0.400 |
Biomarker
|
disease |
CTD_human |
|
|
|